Clinical Trial Update: A Double-Blind, Randomized, Placebo-Controlled Phase IIa Clinical Trial to Evaluate the Safety and Efficacy of DT2-SCT in Subjects With Type 2 Diabetes Mellitus [Phase 2]

View source ↗

Summary

A Phase 2a double-blind, randomized, placebo-controlled trial to assess the safety and efficacy of DT2-SCT in adults with Type 2 Diabetes Mellitus; recruitment …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• DT2-SCT

Snippet

Sponsor: Global Institute of Stem Cell Therapy and Research | Conditions: Type 2 Diabetes Mellitus (T2DM) | Phase 2 | Status: NOT_YET_RECRUITING